Kabra Drugs Limited Press Release Apr 07 2026
Filed with BSE · · 2 pages · English
We enclose herewith a certificate issued by Skyline Financial Services Pvt Ltd, Registrar and Share Transfer Agent of the Company confirming the compliance under the Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2026. Nanjappan Aravind Managing Director
Earlier from Kabra Drugs
- Kabra Drugs Limited Press Release Mar 25 2026
- Kabra Drugs Limited Press Release Feb 26 2026
- Kabra Drugs Limited Press Release Feb 16 2026
- Kabra Drugs Limited Press Release Feb 06 2026
- Kabra Drugs Limited Press Release Jan 06 2026
Later from Kabra Drugs
- Kabra Drugs Limited Press Release Apr 10 2026
- Kabra Drugs Limited Press Release Apr 21 2026
- Kabra Drugs Limited Press Release May 08 2026
- Kabra Drugs Limited Press Release May 30 2026
- Kabra Drugs Limited Press Release Jun 12 2026
Follow Kabra Drugs into a list and get an email when it puts out news.
Follow Kabra Drugs